{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T21:40:11Z","timestamp":1683063611674},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.dld.2005.01.014","type":"journal-article","created":{"date-parts":[[2005,4,8]],"date-time":"2005-04-08T13:19:45Z","timestamp":1112966385000},"page":"515-521","source":"Crossref","is-referenced-by-count":2,"title":["Selective granulocyte and monocyte apheresis as a new adjunct to enhance the efficacy of interferon-alpha+ribavirin in patients with high plasma hepatitis C virus"],"prefix":"10.1016","volume":"37","author":[{"given":"K.","family":"Sawada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kashiwamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Saniabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2005.01.014_bib1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.510230406","article-title":"The natural course of hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C virus","volume":"23","author":"Kobayashi","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2005.01.014_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s005350070060","article-title":"Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course","volume":"35","author":"Arase","year":"2000","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2005.01.014_bib3","first-page":"161","article-title":"Hepatitis C virus and hepatocellular carcinoma","volume":"vol. 62","author":"Kiyosawa","year":"1998"},{"key":"10.1016\/j.dld.2005.01.014_bib4","first-page":"356","article-title":"Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites for the virus","volume":"85","author":"Cravatto","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.dld.2005.01.014_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jmv.1095","article-title":"Study of the infection of human blood derived monocyte\/macrophage with hepatitis C virus in vitro","volume":"65","author":"Caussin-Scwemling","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.dld.2005.01.014_bib6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/infdis\/166.6.1276","article-title":"Hepatitis C is detected in a monocyte macrophage subpopulation of peripheral blood mononuclear cells of infected patients","volume":"166","author":"Bouffard","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.dld.2005.01.014_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","article-title":"Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study","volume":"16","author":"Shimoyama","year":"2001","journal-title":"J Clin Apher"},{"key":"10.1016\/j.dld.2005.01.014_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","article-title":"Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes","volume":"7","author":"Saniabadi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.dld.2005.01.014_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1381612033391928","article-title":"Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column","volume":"9","author":"Sawada","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.dld.2005.01.014_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.1995.tb03620.x","article-title":"Human neutrophil Fc receptor-mediated adhesion under flow: a hallow fiber model of intravascular arrest","volume":"100","author":"D\u2019Arrigo","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2005.01.014_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1526-0968.2003.00049.x","article-title":"Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis","volume":"7","author":"Hiraishi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.dld.2005.01.014_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1525-1594.1997.tb00513.x","article-title":"Granulocytapheresis in the treatment of patients with rheumatoid arthritis","volume":"21","author":"Ohara","year":"1997","journal-title":"Artif Organs"},{"key":"10.1016\/j.dld.2005.01.014_bib13","first-page":"1502","article-title":"Significance of serum hepatitis C virus RNA levels in chronic hepatitis C","volume":"342","author":"Lau","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2005.01.014_bib14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.dld.2004.08.004","article-title":"Clinical evaluation of granulocyte\/monocyte apheresis therapy for active ulcerative colitis","volume":"36","author":"Kanke","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2005.01.014_bib15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM198911303212204","article-title":"Recombinant interferon alpha therapy for chronic hepatitis C: a randomized, double blind placebo-controlled trial","volume":"321","author":"Di Bisceglie","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2005.01.014_bib16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.1840190505","article-title":"Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection","volume":"19","author":"Tsubota","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2005.01.014_bib17","first-page":"228","article-title":"A new treatment for HCV-ulcerative colitis co-morbidity intolerant to IFN-alpha","volume":"98","author":"Sawada","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2005.01.014_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/jcgh.2003.50005","article-title":"Leucocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective uncontrolled pilot study","volume":"1","author":"Hanai","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2005.01.014_bib19","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1023\/A:1015330816364","article-title":"Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis","volume":"47","author":"Kashiwagi","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2005.01.014_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/B:DDAS.0000026299.43792.ae","article-title":"Selective granulocyte and monocyte adsorptive apheresis as a first line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study","volume":"49","author":"Suzuki","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2005.01.014_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.dld.2005.01.014_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1089-3261(02)00068-5","article-title":"Immunopathogenesis of hepatitis C virus infection","volume":"7","author":"Chang","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2005.01.014_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0198-8859(03)00041-7","article-title":"Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection","volume":"64","author":"Sreenarasimhaiah","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1016\/j.dld.2005.01.014_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.hepres.2003.07.001","article-title":"Long-term changes of peripheral blood CD4-positive T cell subsets (Th1, Th2) in chronic hepatitis C patients with a sustained response or no response to IFN","volume":"27","author":"Shinohara","year":"2003","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2005.01.014_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1744-9987.1998.tb00091.x","article-title":"A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis","volume":"2","author":"Kashiwagi","year":"1998","journal-title":"Ther Apher"},{"key":"10.1016\/j.dld.2005.01.014_bib26","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1023\/A:1020159932758","article-title":"Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis","volume":"47","author":"Hanai","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2005.01.014_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1034\/j.1600-065X.2003.00020.x","article-title":"Regulation of cytokine receptor signaling by SOCS1","volume":"192","author":"Ilangumaran","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.dld.2005.01.014_bib28","doi-asserted-by":"crossref","first-page":"22755","DOI":"10.1074\/jbc.M303021200","article-title":"Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other gamma c-dependent cytokines in peripheral T cells","volume":"278","author":"Cornish","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dld.2005.01.014_bib29","doi-asserted-by":"crossref","first-page":"29752","DOI":"10.1074\/jbc.M300489200","article-title":"Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells","volume":"278","author":"Yu","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dld.2005.01.014_bib30","doi-asserted-by":"crossref","first-page":"35056","DOI":"10.1074\/jbc.273.52.35056","article-title":"The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities","volume":"273","author":"Song","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dld.2005.01.014_bib31","doi-asserted-by":"crossref","first-page":"22086","DOI":"10.1074\/jbc.M102737200","article-title":"Suppressor of cytokine signaling-1 attenuates the duration of interferon gamma signal transduction in vitro and in vivo","volume":"276","author":"Brysha","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dld.2005.01.014_bib32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1096\/fj.02-0664fje","article-title":"IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3","volume":"17","author":"Bode","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.dld.2005.01.014_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01893020","article-title":"Structure and functions of anaphylotoxins","volume":"7","author":"Hugli","year":"1984","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.dld.2005.01.014_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0165-6147(85)90053-7","article-title":"Drugs and the complement system","volume":"6","author":"Vogt","year":"1985","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.dld.2005.01.014_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0065-2776(08)60341-7","article-title":"Membrane complement receptors specific for bound fragments of C3","volume":"37","author":"Ross","year":"1985","journal-title":"Adv Immunol"},{"key":"10.1016\/j.dld.2005.01.014_bib36","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.4049\/jimmunol.157.12.5660","article-title":"CR3 (alphaM beta2; CD11b\/CD18) restores IgG-dependent phagocytosis in transfectants expressing a phagocytosis-defective Fc gammaRIIA (CD32) tail-minus mutant","volume":"157","author":"Worth","year":"1996","journal-title":"J Immunol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865805000915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865805000915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T21:22:18Z","timestamp":1683062538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865805000915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S1590865805000915"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2005.01.014","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}